Case Report
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jun 6, 2021; 9(16): 4032-4039
Published online Jun 6, 2021. doi: 10.12998/wjcc.v9.i16.4032
Transient immune hepatitis as post-coronavirus disease complication: A case report
Anca Cristina Drăgănescu, Oana Săndulescu, Anuța Bilașco, Camelia Kouris, Anca Streinu-Cercel, Monica Luminos, Adrian Streinu-Cercel
Anca Cristina Drăgănescu, Oana Săndulescu, Anuța Bilașco, Camelia Kouris, Anca Streinu-Cercel, Monica Luminos, Adrian Streinu-Cercel, Infectious Diseases Department, National Institute for Infectious Diseases “Prof. Dr. Matei Balș”, Bucharest 021105, Romania
Oana Săndulescu, Anca Streinu-Cercel, Monica Luminos, Adrian Streinu-Cercel, Infectious Diseases Department,Carol Davila University of Medicine and Pharmacy, Bucharest 021105, Romania
Author contributions: Drăgănescu AC, Săndulescu O, Bilașco A, Kouris C, Streinu-Cercel An, Luminos M, and Streinu-Cercel Ad had equal contributions to the article and were involved in patient management, acquisition, analysis, or interpretation of data for the work; drafted the work or revised it critically for important intellectual content; gave final approval of the version to be published, and agree to be accountable for all aspects of the work.
Informed consent statement: Written informed consent was obtained from the patient for the publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Oana Săndulescu, MD, PhD, Associate Professor, Infectious Diseases Department, National Institute for Infectious Diseases “Prof. Dr. Matei Bals”, Carol Davila University of Medicine and Pharmacy, No. 1 Dr. Calistrat Grozovici Street, Bucharest 021105, Romania. oana.sandulescu@umfcd.ro
Received: January 12, 2021
Peer-review started: January 12, 2021
First decision: February 11, 2021
Revised: February 25, 2021
Accepted: March 24, 2021
Article in press: March 24, 2021
Published online: June 6, 2021
Core Tip

Core Tip: We report an interesting case of post-coronavirus disease immune hepatitis occurring in a young male with no pre-existing comorbidities. The patient acquired the infection from an asymptomatic carrier of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). He developed a mild form of disease, but after apparent clinical remission and real-time reverse transcription polymerase chain reaction negative conversion, an important increase in liver enzymes was recorded in parallel with an increasing SARS-CoV-2 antibody titer.